Based on a possible involvement of serotonergic dysfunction in the pathophysiology of fibromyalgia (FM) and on preliminary reports of a possible genetically driven vulnerability for this disorder we investigated the silent T102C polymorphism of the 5-HT2A-receptor gene in 168 FM patients and 115 healthy controls. Our results showed a significantly different genotype distribution in FM patients with a decrease in T/T and an increase in both T/C and C/C genotypes as compared to the control population (Fisher's Exact test, two-sided, P ‫؍‬ 0.008). However, the increase in allele-C102 frequency felt short of significance (P ‫؍‬ 0.07). Correlation of genotypes to clinical parameters revealed no influences on age of onset, duration of disease or psychopathological symptoms, measured with the Beck Depression Inventory and the symptom checklist SCL-90-R. In contrast to that the pain score, being a self reported information on pain severity, was significantly higher in patients of the T/T genotype (Mann-Whitney U test, P ‫؍‬ 0.028). This suggests that the T102-allele might be involved in the complex circuits of nociception. However, the T102C polymorphism is not directly involved in the aetiology of FM but might be in linkage dysequilibrium with the true functional variant, which has to be unravelled.
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INTRODUCTION
Fibromyalgia (FM) is a syndrome of generalized musculoskeletal pain and tenderness at multiple characteristic sites (Fassbender et al., 1997) . Several additional clinical features of FM, including depression, anxiety, sleep disturbances, as well as an increased familial loading with depressive disorders, have lead to the suggestion that FM might be a ''depressive spectrum disorder '' (Hudson and Pope, 1994) . This assumption was further supported by positive therapeutic response to antidepressant drugs (Johnson, 1997) , as well as by the fact that pain is a frequent complaint during depression and may thus share common neurochemical pathway (Von et al., 1987) .
Further, the pain perception threshold was found to be decreased during depression (Ward et al., 1982) , which was considered as being attributable to dysfunction in several neurotransmitter systems, especially the serotonergic one, which is also involved in the pathophysiology of depression (van Praag et al., 1990) .
A possible contribution of serotonin (5-HT) to the aetiology of FM has been suggested not only due to the efficacy of serotonin-reuptake inhibitors in the management of chronic pain (Jung et al., 1997) , but also on the basis of multiple biological findings, as, e.g., low levels of serum serotonin (Wolfe et al., 1997) and low 5-hydroxyindole acetic acid (5-HIAA) levels in cerebrospinal fluid (CSF) of idiopathic pain patients (Almay et al., 1987) . Further, since tryptophan supplementation was
